MedCap AB MCAP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 486.00
- Day Range
- SEK 480.00–491.50
- 52-Week Range
- SEK 247.00–624.00
- Bid/Ask
- SEK 487.00 / SEK 489.00
- Market Cap
- SEK 7.19 Bil
- Volume/Avg
- 6,987 / 15,438
Key Statistics
- Price/Earnings (Normalized)
- 36.25
- Price/Sales
- 4.16
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 530
- Website
- https://www.medcap.se
Comparables
Valuation
|
Metric
|
MCAP
|
LINC
|
ORES
|
|---|---|---|---|
Price/Earnings (Normalized) | 36.25 | 3.18 | 7.40 |
Price/Book Value | 6.27 | 1.08 | 1.15 |
Price/Sales | 4.16 | — | 7.04 |
Price/Cash Flow | 24.01 | — | 35.26 |
Price/Earnings
MCAP
LINC
ORES
Financial Strength
|
Metric
|
MCAP
|
LINC
|
ORES
|
|---|---|---|---|
Quick Ratio | 1.62 | 167.52 | — |
Current Ratio | 2.39 | 167.52 | — |
Interest Coverage | 16.12 | 309.95 | — |
Quick Ratio
MCAP
LINC
ORES
Profitability
|
Metric
|
MCAP
|
LINC
|
ORES
|
|---|---|---|---|
Return on Assets (Normalized) | 12.60% | 0.08% | 16.29% |
Return on Equity (Normalized) | 20.57% | 0.08% | 16.75% |
Return on Invested Capital (Normalized) | 16.61% | −0.31% | — |
Return on Assets
MCAP
LINC
ORES
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Qkjthmym | Rwldxd | $195.3 Bil | |||
| Stryker Corp
SYK
| Grbfnkfjbz | Sdk | $134.0 Bil | |||
| Boston Scientific Corp
BSX
| Qjxyntzv | Fwrwnh | $123.4 Bil | |||
| Medtronic PLC
MDT
| Wcvxmtsk | Nxpynh | $112.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Rcbffxrpfw | Lycqyh | $39.4 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Qqswx | Zdyd | $30.1 Bil | |||
| DexCom Inc
DXCM
| Qymsgjck | Cchhn | $26.3 Bil | |||
| Steris PLC
STE
| Hyhjdccxr | Fpkmw | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Ghwtglsr | Kcrz | $21.2 Bil | |||
| Insulet Corp
PODD
| Wynvwpgdk | Wnmyds | $16.1 Bil |
United States